168 - What’s Old Is New: Vaccine-Preventable Diseases

Tuesday, October 21, 2025

1:45 PM - 3:00 PM US ET

Location: Thomas B. Murphy Ballroom 2-3

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Catherine Mary Healy, MD, FIDSA (she/her/hers)

Associate Professor of Pediatrics
Baylor College of Medicine
Houston, TX, United States
Caitlin Li, MD MHQS (she/her/hers)

Assistant Professor of Pediatrics
Lurie Childrens Hospital
Chicago, IL, United States

Faculty(s)

Yvonne Maldonado, MD

Senior Associate Dean for Faculty Development and Diversity Taube Endowed Professor of Global Health and Infectious Diseases Professor of Pediatrics (Infectious Diseases) and of Epidemiology and Population Health
Standford University School of Medicine
Stanford, CA, United States
JC

James Campbell
ME

Morven Edwards, MD

Distinguished Emeritus Professor of Pediatrics
Baylor College of Medicine
Bellaire, TX, United States

Disclosure(s):

Catherine Mary Healy, MD, FIDSA: Dexcom, Inc: Stocks/Bonds (Public Company); Hillevax, Inc: Advisor/Consultant; Intuitive Surgical, Inc: Stocks/Bonds (Public Company); Quidel Diagnostics: Stocks/Bonds (Public Company); UpToDate Wolters Kluwer Health: Honoraria; Vindico CME: Honoraria

Caitlin Li, MD MHQS: No financial relationships to disclose.

Yvonne Maldonado, MD: Pfizer, Inc.: Grant/Research Support, Past Member, DSMB

James Campbell: GSK: Grant/Research Support; Merck: Grant/Research Support; Moderna: Grant/Research Support; Pfizer: Grant/Research Support; Sanofi: Grant/Research Support

Morven S. Edwards, MD: No financial relationships to disclose.

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the clinical presentation of vaccine preventable diseases;
describethe natural history of specific vaccinepreventable disease that may be unfamiliar to clinicians;
define some "clinical pearls" that may aid healthcare providers in recognizing, diagnosing and treating vaccine-preventable diseases;
define the real-world consequences of resurgences of vaccine-preventable disease.

Presentations:

1:45 PM - 2:10 PM US ET

Viral Infections You Must Not Forget
Speaker: Morven S. Edwards, MD – Baylor College of Medicine
2:10 PM - 2:35 PM US ET

What's This Rash?
Speaker: James Campbell
2:35 PM - 3:00 PM US ET

Real-World Consequences of Vaccine-Preventable Diseases
Speaker: Yvonne Maldonado, MD – Standford University School of Medicine